Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Assessment of the HyperQ Signal for Detecting Ischemia During Dobutamine Stress Echocardiography (DSE)

NCT00310622 is registered in ClinicalTrials.gov with BSP Biological Signal Processing Ltd. as lead sponsor.

NCT NCT00310622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00310622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Assessment of the HyperQ Signal for Detecting Ischemia During Dobutamine Stress Echocardiography (DSE)
Lead sponsor
BSP Biological Signal Processing Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2006
Completion date
February 28, 2007
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial ischemia